This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Covering all areas of neoplastic and nonneoplastic diseases of the digestive tract and accessory organs such as the pancreas and liver, it incorporates the most recent clinical, pathological, and molecular knowledge in the field to provide a comprehensive overview of all key issues relevant to today’s practice. Richly illustrated and easy to use, Diagnostic Pathology: Hepatobiliary and Pancreas is a one-stop reference for accurate, complete pathology reports, ideal as a day-to-day reference or as a reliable training resource.
Analyzes hundreds of diagnoses, each of which include critical diagnostic information such as definitions, epidemiology, clinical presentation, macro- and microscopic features, differential diagnoses, and pathologic interpretation pearls.
Features thorough updates throughout, including novel immunohistochemical markers and other ancillary techniques (such as BAP1, INSM1, Rb, albumin in situ hybridization) that play an increasingly critical role in improving diagnoses
Addresses recent advances in molecular pathology—new diagnostic, immunohistochemical, molecular, and genetic techniques used for diagnosis, as well as new details about the genesis and activity of tumors in the liver, pancreas, and biliary systems
Includes details from the 2019 WHO Classification of Tumors of the Digestive System regarding important changes to diagnostic techniques, identification of new variants of cancers, and immunohistochemical markers and ancillary techniques that improve diagnosis and treatment options
Reflects recent WHO updates and updates from the AJCC’s 8th Edition Cancer Staging Manual such as new terminology, new grading of neuroendocrine tumors and neuroendocrine carcinomas, and characteristic molecular alterations in hepatocellular adenoma, cholangiocarcinoma, and other tumors
Uses a templated page layout, bulleted text, and a generous number of high-quality images to help practicing and in-training pathologists reach a confident diagnosis
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedications - p. iii 6. Contributing Authors - p. v 7. Preface - p. v 8. Acknowledgments - p. v 9. Sections - p. ix 10. Part I: Liver - p. xiii 11. SECTION 1: INHERITED, METABOLIC, AND DEVELOPMENTAL DISORDERS - p. xiii 12. Chapter 1: Glycogen Storage Disease, Hepatic - p. xiii 13. Chapter 2: Tyrosinemia - p. 9 14. Chapter 3: Niemann-Pick Disease - p. 11 15. Chapter 4: Gaucher Disease - p. 13 16. Chapter 5: Neonatal Hemochromatosis - p. 15 17. Chapter 6: Porphyrin Metabolism Disorders - p. 17 18. Chapter 7: Dubin-Johnson Syndrome - p. 23 19. Chapter 8: Gilbert Disease - p. 25 20. Chapter 9: Progressive Familial Intrahepatic Cholestasis - p. 27 21. Chapter 10: Cystic Fibrosis, Hepatic - p. 35 22. Chapter 11: Hereditary Hemochromatosis - p. 39 23. Chapter 12: Wilson Disease - p. 43 24. Chapter 13: Alpha-1-Antitrypsin Deficiency - p. 49 25. Chapter 14: Congenital Hepatic Fibrosis - p. 53 26. Chapter 15: Polycystic Liver Disease - p. 55 27. Chapter 16: Caroli Disease - p. 57 28. SECTION 2: INFECTIOUS DISORDERS - p. 59 29. Chapter 17: Overview of Hepatitis - p. 59 30. Chapter 18: Acute Viral Hepatitis - p. 67 31. Chapter 19: Hepatitis B - p. 71 32. Chapter 20: Hepatitis C - p. 75 33. Chapter 21: Hepatitis E - p. 79 34. Chapter 22: Epstein-Barr Virus - p. 83 35. Chapter 23: Cytomegalovirus - p. 87 36. Chapter 24: Herpes Simplex Virus - p. 89 37. Chapter 25: Adenovirus - p. 91 38. Chapter 26: Pyogenic Abscess - p. 93 39. Chapter 27: Sepsis in the Liver - p. 97 40. Chapter 28: Mycobacterium tuberculosis - p. 99 41. Chapter 29: Atypical Mycobacteria - p. 103 42. Chapter 30: Cat-Scratch Disease - p. 107 43. Chapter 31: Candidiasis - p. 109 44. Chapter 32: Histoplasmosis - p. 111 45. Chapter 33: Cryptococcosis - p. 115 46. Chapter 34: Amebiasis - p. 117 47. Chapter 35: Schistosomiasis - p. 121 48. Chapter 36: Echinococcosis - p. 123 49. SECTION 3: CHRONIC CHOLESTATIC AND AUTOIMMUNE DISORDERS - p. 125 50. Chapter 37: Autoimmune Hepatitis - p. 125 51. Chapter 38: Primary Biliary Cholangitis - p. 133 52. Chapter 39: Primary Sclerosing Cholangitis - p. 139 53. Chapter 40: Ischemic Cholangitis - p. 145 54. Chapter 41: Large Bile Duct Obstruction - p. 147 55. Chapter 42: Idiopathic Adulthood Ductopenia - p. 151 56. SECTION 4: PEDIATRIC CHOLESTATIC DISORDERS - p. 153 57. Chapter 43: Biliary Atresia - p. 153 58. Chapter 44: Neonatal Hepatitis - p. 159 59. Chapter 45: Syndromic Paucity of Intrahepatic Bile Ducts (Alagille Syndrome) - p. 161 60. Chapter 46: Nonsyndromic Paucity of Intrahepatic Bile Ducts - p. 165 61. SECTION 5: DRUG/TOXIN-RELATED HEPATITIS - p. 169 62. Chapter 47: Drug-Induced Acute Hepatitis - p. 169 63. Chapter 48: Drug-Induced Acute Hepatic Failure - p. 177 64. Chapter 49: Drug-Induced Cholestatic Liver Injury - p. 181 65. Chapter 50: Drug-Induced Granulomatous Hepatitis - p. 183 66. Chapter 51: Drug-Induced Steatohepatitis/Phospholipidosis - p. 187 67. Chapter 52: Reye Syndrome - p. 191 68. Chapter 53: Drug-Induced Cholangitis/Ductopenia - p. 193 69. Chapter 54: Hepatic Stellate Cell Hyperplasia - p. 199 70. SECTION 6: FATTY LIVER DISEASES - p. 201 71. Chapter 55: Alcoholic Liver Disease - p. 201 72. Chapter 56: Nonalcoholic Steatohepatitis - p. 209 73. Chapter 57: Glycogenic Hepatopathy - p. 217 74. Chapter 58: Fatty Liver of Pregnancy - p. 219 75. SECTION 7: VASCULAR DISORDERS - p. 221 76. Chapter 59: Portal Venous Obstruction - p. 221 77. Chapter 60: Hepatoportal Sclerosis - p. 225 78. Chapter 61: Hepatic Venous Outflow Obstruction - p. 227 79. Chapter 62: Venoocclusive Disease - p. 231 80. Chapter 63: Amyloidosis - p. 233 81. Chapter 64: Ischemia - p. 235 82. Chapter 65: Nodular Regenerative Hyperplasia - p. 237 83. SECTION 8: TRANSPLANTATION PATHOLOGY - p. 239 84. Chapter 66: Ischemia Reperfusion Injury - p. 239 85. Chapter 67: Antibody-Mediated Rejection - p. 243 86. Chapter 68: T-Cell-Mediated Rejection (Acute Cellular Rejection) - p. 245 87. Chapter 69: Chronic Rejection - p. 249 88. Chapter 70: Central Perivenulitis/Parenchymal Rejection - p. 251 89. Chapter 71: Hepatic Artery Thrombosis - p. 253 90. Chapter 72: Graft-vs.-Host Disease - p. 255 91. SECTION 9: TUMORS OF THE LIVER - p. 257 92. Chapter 73: Hepatocellular Adenoma - p. 257 93. Chapter 74: Focal Nodular Hyperplasia - p. 267 94. Chapter 75: Regenerative and Dysplastic Nodules - p. 271 95. Chapter 76: Hepatocellular Carcinoma and Variants - p. 277 96. Chapter 77: Fibrolamellar Carcinoma - p. 289 97. Chapter 78: Combined Hepatocellular-Cholangiocarcinoma - p. 293 98. Chapter 79: Hepatoblastoma - p. 297 99. Chapter 80: Bile Duct Adenoma - p. 301 100. Chapter 81: von Meyenburg Complex (Biliary Microhamartoma) - p. 303 101. Chapter 82: Mucinous Cystic Neoplasm, Liver - p. 305 102. Chapter 83: Intrahepatic Cholangiocarcinoma - p. 309 103. Chapter 84: Intrahepatic Cholangiocarcinoma, Histologic Subtypes - p. 313 104. Chapter 85: Intraductal Papillary Neoplasm of the Bile Duct - p. 317 105. Chapter 86: Hemangioma - p. 319 106. Chapter 87: Angiomyolipoma - p. 321 107. Chapter 88: Hepatic Small Vessel Neoplasm/Anastamosing Hemangioma - p. 325 108. Chapter 89: Epithelioid Hemangioendothelioma - p. 329 109. Chapter 90: Infantile Hemangioma - p. 331 110. Chapter 91: Angiosarcoma - p. 333 111. Chapter 92: Mesenchymal Hamartoma - p. 335 112. Chapter 93: Embryonal Sarcoma - p. 337 113. Chapter 94: Inflammatory Pseudotumor - p. 339 114. Chapter 95: Segmental Atrophy (Nodular Elastosis) - p. 345 115. Chapter 96: Hepatectomy Specimen Handling - p. 347 116. SECTION 10: MISCELLANEOUS HEPATIC DISORDERS - p. 349 117. Chapter 97: Langerhans Cell Histiocytosis - p. 349 118. Chapter 98: Hemophagocytic Syndromes - p. 355 119. Part II: Pancreas and Biliary Tract - p. 357 120. SECTION 1: DEVELOPMENTAL/CONGENITAL - p. 357 121. Chapter 99: Congenital Pancreatic Cyst - p. 357 122. Chapter 100: Cystic Fibrosis, Pancreatic - p. 361 123. Chapter 101: Nesidioblastosis - p. 363 124. Chapter 102: Choledochal Cyst - p. 365 125. SECTION 2: INFLAMMATORY DISORDERS OF THE GALLBLADDER AND EXTRAHEPATIC BILIARY TREE - p. 367 126. Chapter 103: Cholelithiasis - p. 367 127. Chapter 104: Acute Cholecystitis - p. 371 128. Chapter 105: Chronic Cholecystitis - p. 373 129. Chapter 106: Xanthogranulomatous Cholecystitis - p. 375 130. Chapter 107: Eosinophilic Cholecystitis - p. 377 131. Chapter 108: Polyarteritis Nodosa and Other Vasculitides - p. 379 132. Chapter 109: Parasitic Infection - p. 381 133. SECTION 3: NONNEOPLASTIC AND INFLAMMATORY DISORDERS OF THE PANCREAS - p. 385 134. Chapter 110: Acute Pancreatitis - p. 385 135. Chapter 111: Chronic Pancreatitis - p. 389 136. Chapter 112: Autoimmune Pancreatitis - p. 393 137. Chapter 113: Groove Pancreatitis - p. 397 138. Chapter 114: Infectious Pancreatitis - p. 399 139. Chapter 115: Pseudocysts - p. 401 140. Chapter 116: Diabetes Mellitus - p. 403 141. Chapter 117: Lymphoepithelial Cyst of the Pancreas - p. 405 142. SECTION 4: TUMORS OF THE GALLBLADDER AND EXTRAHEPATIC BILIARY TREE - p. 407 143. Chapter 118: Noninvasive Epithelial Polypoid Lesions - p. 407 144. Chapter 119: Carcinoma of Gallbladder - p. 413 145. Chapter 120: Carcinoma of Extrahepatic Bile Ducts - p. 419 146. Chapter 121: Squamous/Adenosquamous Carcinoma, Gallbladder - p. 425 147. Chapter 122: Neuroendocrine Neoplasms of Gallbladder - p. 427 148. Chapter 123: Granular Cell Tumor - p. 431 149. Chapter 124: Embryonal Rhabdomyosarcoma - p. 433 150. Chapter 125: Adenomyoma - p. 435 151. Chapter 126: Nonneoplastic Polypoid Gallbladder Lesions - p. 437 152. SECTION 5: TUMORS OF THE PANCREAS - p. 441 153. Chapter 127: Pancreatic Intraepithelial Neoplasia - p. 441 154. Chapter 128: Ductal Adenocarcinoma, Including Histologic Subtypes - p. 445 155. Chapter 129: Undifferentiated Carcinoma - p. 449 156. Chapter 130: Squamous/Adenosquamous Carcinoma, Pancreas - p. 451 157. Chapter 131: Acinar Cell Carcinoma - p. 453 158. Chapter 132: Serous Cystadenoma - p. 457 159. Chapter 133: Acinar Cell Cystadenoma - p. 461 160. Chapter 134: Well-Differentiated Neuroendocrine Tumor, Pancreas - p. 465 161. Chapter 135: Poorly Differentiated Neuroendocrine Carcinoma, Pancreas - p. 471 162. Chapter 136: Simple Mucinous Cyst - p. 475 163. Chapter 137: Mucinous Cystic Neoplasm, Pancreas - p. 477 164. Chapter 138: Intraductal Papillary Mucinous Neoplasm - p. 481 165. Chapter 139: Intraductal Oncocytic Papillary Neoplasm - p. 487 166. Chapter 140: Intraductal Tubulopapillary Neoplasm - p. 489 167. Chapter 141: Solid Pseudopapillary Neoplasm - p. 491 168. Chapter 142: Pancreatoblastoma - p. 495 169. Chapter 143: Dermoid Cyst - p. 497 170. Chapter 144: Specimen Handling, Whipple - p. 499 171. SECTION 6: TUMORS OF THE AMPULLA - p. 503 172. Chapter 145: Ampullary Adenoma - p. 503 173. Chapter 146: Ampullary Adenocarcinoma and Histologic Subtypes - p. 507 174. Chapter 147: Well-Differentiated Neuroendocrine Tumor, Ampulla - p. 511 175. Chapter 148: Gangliocytic Paraganglioma - p. 513 176. INDEX - p. 515
This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Covering all areas of neoplastic and nonneoplastic diseases of the digestive tract and accessory organs such as the pancreas and liver, it incorporates the most recent clinical, pathological, and molecular knowledge in the field to provide a comprehensive overview of all key issues relevant to today’s practice. Richly illustrated and easy to use, Diagnostic Pathology: Hepatobiliary and Pancreas is a one-stop reference for accurate, complete pathology reports, ideal as a day-to-day reference or as a reliable training resource.
Analyzes hundreds of diagnoses, each of which include critical diagnostic information such as definitions, epidemiology, clinical presentation, macro- and microscopic features, differential diagnoses, and pathologic interpretation pearls.
Features thorough updates throughout, including novel immunohistochemical markers and other ancillary techniques (such as BAP1, INSM1, Rb, albumin in situ hybridization) that play an increasingly critical role in improving diagnoses
Addresses recent advances in molecular pathology—new diagnostic, immunohistochemical, molecular, and genetic techniques used for diagnosis, as well as new details about the genesis and activity of tumors in the liver, pancreas, and biliary systems
Includes details from the 2019 WHO Classification of Tumors of the Digestive System regarding important changes to diagnostic techniques, identification of new variants of cancers, and immunohistochemical markers and ancillary techniques that improve diagnosis and treatment options
Reflects recent WHO updates and updates from the AJCC’s 8th Edition Cancer Staging Manual such as new terminology, new grading of neuroendocrine tumors and neuroendocrine carcinomas, and characteristic molecular alterations in hepatocellular adenoma, cholangiocarcinoma, and other tumors
Uses a templated page layout, bulleted text, and a generous number of high-quality images to help practicing and in-training pathologists reach a confident diagnosis
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedications - p. iii 6. Contributing Authors - p. v 7. Preface - p. v 8. Acknowledgments - p. v 9. Sections - p. ix 10. Part I: Liver - p. xiii 11. SECTION 1: INHERITED, METABOLIC, AND DEVELOPMENTAL DISORDERS - p. xiii 12. Chapter 1: Glycogen Storage Disease, Hepatic - p. xiii 13. Chapter 2: Tyrosinemia - p. 9 14. Chapter 3: Niemann-Pick Disease - p. 11 15. Chapter 4: Gaucher Disease - p. 13 16. Chapter 5: Neonatal Hemochromatosis - p. 15 17. Chapter 6: Porphyrin Metabolism Disorders - p. 17 18. Chapter 7: Dubin-Johnson Syndrome - p. 23 19. Chapter 8: Gilbert Disease - p. 25 20. Chapter 9: Progressive Familial Intrahepatic Cholestasis - p. 27 21. Chapter 10: Cystic Fibrosis, Hepatic - p. 35 22. Chapter 11: Hereditary Hemochromatosis - p. 39 23. Chapter 12: Wilson Disease - p. 43 24. Chapter 13: Alpha-1-Antitrypsin Deficiency - p. 49 25. Chapter 14: Congenital Hepatic Fibrosis - p. 53 26. Chapter 15: Polycystic Liver Disease - p. 55 27. Chapter 16: Caroli Disease - p. 57 28. SECTION 2: INFECTIOUS DISORDERS - p. 59 29. Chapter 17: Overview of Hepatitis - p. 59 30. Chapter 18: Acute Viral Hepatitis - p. 67 31. Chapter 19: Hepatitis B - p. 71 32. Chapter 20: Hepatitis C - p. 75 33. Chapter 21: Hepatitis E - p. 79 34. Chapter 22: Epstein-Barr Virus - p. 83 35. Chapter 23: Cytomegalovirus - p. 87 36. Chapter 24: Herpes Simplex Virus - p. 89 37. Chapter 25: Adenovirus - p. 91 38. Chapter 26: Pyogenic Abscess - p. 93 39. Chapter 27: Sepsis in the Liver - p. 97 40. Chapter 28: Mycobacterium tuberculosis - p. 99 41. Chapter 29: Atypical Mycobacteria - p. 103 42. Chapter 30: Cat-Scratch Disease - p. 107 43. Chapter 31: Candidiasis - p. 109 44. Chapter 32: Histoplasmosis - p. 111 45. Chapter 33: Cryptococcosis - p. 115 46. Chapter 34: Amebiasis - p. 117 47. Chapter 35: Schistosomiasis - p. 121 48. Chapter 36: Echinococcosis - p. 123 49. SECTION 3: CHRONIC CHOLESTATIC AND AUTOIMMUNE DISORDERS - p. 125 50. Chapter 37: Autoimmune Hepatitis - p. 125 51. Chapter 38: Primary Biliary Cholangitis - p. 133 52. Chapter 39: Primary Sclerosing Cholangitis - p. 139 53. Chapter 40: Ischemic Cholangitis - p. 145 54. Chapter 41: Large Bile Duct Obstruction - p. 147 55. Chapter 42: Idiopathic Adulthood Ductopenia - p. 151 56. SECTION 4: PEDIATRIC CHOLESTATIC DISORDERS - p. 153 57. Chapter 43: Biliary Atresia - p. 153 58. Chapter 44: Neonatal Hepatitis - p. 159 59. Chapter 45: Syndromic Paucity of Intrahepatic Bile Ducts (Alagille Syndrome) - p. 161 60. Chapter 46: Nonsyndromic Paucity of Intrahepatic Bile Ducts - p. 165 61. SECTION 5: DRUG/TOXIN-RELATED HEPATITIS - p. 169 62. Chapter 47: Drug-Induced Acute Hepatitis - p. 169 63. Chapter 48: Drug-Induced Acute Hepatic Failure - p. 177 64. Chapter 49: Drug-Induced Cholestatic Liver Injury - p. 181 65. Chapter 50: Drug-Induced Granulomatous Hepatitis - p. 183 66. Chapter 51: Drug-Induced Steatohepatitis/Phospholipidosis - p. 187 67. Chapter 52: Reye Syndrome - p. 191 68. Chapter 53: Drug-Induced Cholangitis/Ductopenia - p. 193 69. Chapter 54: Hepatic Stellate Cell Hyperplasia - p. 199 70. SECTION 6: FATTY LIVER DISEASES - p. 201 71. Chapter 55: Alcoholic Liver Disease - p. 201 72. Chapter 56: Nonalcoholic Steatohepatitis - p. 209 73. Chapter 57: Glycogenic Hepatopathy - p. 217 74. Chapter 58: Fatty Liver of Pregnancy - p. 219 75. SECTION 7: VASCULAR DISORDERS - p. 221 76. Chapter 59: Portal Venous Obstruction - p. 221 77. Chapter 60: Hepatoportal Sclerosis - p. 225 78. Chapter 61: Hepatic Venous Outflow Obstruction - p. 227 79. Chapter 62: Venoocclusive Disease - p. 231 80. Chapter 63: Amyloidosis - p. 233 81. Chapter 64: Ischemia - p. 235 82. Chapter 65: Nodular Regenerative Hyperplasia - p. 237 83. SECTION 8: TRANSPLANTATION PATHOLOGY - p. 239 84. Chapter 66: Ischemia Reperfusion Injury - p. 239 85. Chapter 67: Antibody-Mediated Rejection - p. 243 86. Chapter 68: T-Cell-Mediated Rejection (Acute Cellular Rejection) - p. 245 87. Chapter 69: Chronic Rejection - p. 249 88. Chapter 70: Central Perivenulitis/Parenchymal Rejection - p. 251 89. Chapter 71: Hepatic Artery Thrombosis - p. 253 90. Chapter 72: Graft-vs.-Host Disease - p. 255 91. SECTION 9: TUMORS OF THE LIVER - p. 257 92. Chapter 73: Hepatocellular Adenoma - p. 257 93. Chapter 74: Focal Nodular Hyperplasia - p. 267 94. Chapter 75: Regenerative and Dysplastic Nodules - p. 271 95. Chapter 76: Hepatocellular Carcinoma and Variants - p. 277 96. Chapter 77: Fibrolamellar Carcinoma - p. 289 97. Chapter 78: Combined Hepatocellular-Cholangiocarcinoma - p. 293 98. Chapter 79: Hepatoblastoma - p. 297 99. Chapter 80: Bile Duct Adenoma - p. 301 100. Chapter 81: von Meyenburg Complex (Biliary Microhamartoma) - p. 303 101. Chapter 82: Mucinous Cystic Neoplasm, Liver - p. 305 102. Chapter 83: Intrahepatic Cholangiocarcinoma - p. 309 103. Chapter 84: Intrahepatic Cholangiocarcinoma, Histologic Subtypes - p. 313 104. Chapter 85: Intraductal Papillary Neoplasm of the Bile Duct - p. 317 105. Chapter 86: Hemangioma - p. 319 106. Chapter 87: Angiomyolipoma - p. 321 107. Chapter 88: Hepatic Small Vessel Neoplasm/Anastamosing Hemangioma - p. 325 108. Chapter 89: Epithelioid Hemangioendothelioma - p. 329 109. Chapter 90: Infantile Hemangioma - p. 331 110. Chapter 91: Angiosarcoma - p. 333 111. Chapter 92: Mesenchymal Hamartoma - p. 335 112. Chapter 93: Embryonal Sarcoma - p. 337 113. Chapter 94: Inflammatory Pseudotumor - p. 339 114. Chapter 95: Segmental Atrophy (Nodular Elastosis) - p. 345 115. Chapter 96: Hepatectomy Specimen Handling - p. 347 116. SECTION 10: MISCELLANEOUS HEPATIC DISORDERS - p. 349 117. Chapter 97: Langerhans Cell Histiocytosis - p. 349 118. Chapter 98: Hemophagocytic Syndromes - p. 355 119. Part II: Pancreas and Biliary Tract - p. 357 120. SECTION 1: DEVELOPMENTAL/CONGENITAL - p. 357 121. Chapter 99: Congenital Pancreatic Cyst - p. 357 122. Chapter 100: Cystic Fibrosis, Pancreatic - p. 361 123. Chapter 101: Nesidioblastosis - p. 363 124. Chapter 102: Choledochal Cyst - p. 365 125. SECTION 2: INFLAMMATORY DISORDERS OF THE GALLBLADDER AND EXTRAHEPATIC BILIARY TREE - p. 367 126. Chapter 103: Cholelithiasis - p. 367 127. Chapter 104: Acute Cholecystitis - p. 371 128. Chapter 105: Chronic Cholecystitis - p. 373 129. Chapter 106: Xanthogranulomatous Cholecystitis - p. 375 130. Chapter 107: Eosinophilic Cholecystitis - p. 377 131. Chapter 108: Polyarteritis Nodosa and Other Vasculitides - p. 379 132. Chapter 109: Parasitic Infection - p. 381 133. SECTION 3: NONNEOPLASTIC AND INFLAMMATORY DISORDERS OF THE PANCREAS - p. 385 134. Chapter 110: Acute Pancreatitis - p. 385 135. Chapter 111: Chronic Pancreatitis - p. 389 136. Chapter 112: Autoimmune Pancreatitis - p. 393 137. Chapter 113: Groove Pancreatitis - p. 397 138. Chapter 114: Infectious Pancreatitis - p. 399 139. Chapter 115: Pseudocysts - p. 401 140. Chapter 116: Diabetes Mellitus - p. 403 141. Chapter 117: Lymphoepithelial Cyst of the Pancreas - p. 405 142. SECTION 4: TUMORS OF THE GALLBLADDER AND EXTRAHEPATIC BILIARY TREE - p. 407 143. Chapter 118: Noninvasive Epithelial Polypoid Lesions - p. 407 144. Chapter 119: Carcinoma of Gallbladder - p. 413 145. Chapter 120: Carcinoma of Extrahepatic Bile Ducts - p. 419 146. Chapter 121: Squamous/Adenosquamous Carcinoma, Gallbladder - p. 425 147. Chapter 122: Neuroendocrine Neoplasms of Gallbladder - p. 427 148. Chapter 123: Granular Cell Tumor - p. 431 149. Chapter 124: Embryonal Rhabdomyosarcoma - p. 433 150. Chapter 125: Adenomyoma - p. 435 151. Chapter 126: Nonneoplastic Polypoid Gallbladder Lesions - p. 437 152. SECTION 5: TUMORS OF THE PANCREAS - p. 441 153. Chapter 127: Pancreatic Intraepithelial Neoplasia - p. 441 154. Chapter 128: Ductal Adenocarcinoma, Including Histologic Subtypes - p. 445 155. Chapter 129: Undifferentiated Carcinoma - p. 449 156. Chapter 130: Squamous/Adenosquamous Carcinoma, Pancreas - p. 451 157. Chapter 131: Acinar Cell Carcinoma - p. 453 158. Chapter 132: Serous Cystadenoma - p. 457 159. Chapter 133: Acinar Cell Cystadenoma - p. 461 160. Chapter 134: Well-Differentiated Neuroendocrine Tumor, Pancreas - p. 465 161. Chapter 135: Poorly Differentiated Neuroendocrine Carcinoma, Pancreas - p. 471 162. Chapter 136: Simple Mucinous Cyst - p. 475 163. Chapter 137: Mucinous Cystic Neoplasm, Pancreas - p. 477 164. Chapter 138: Intraductal Papillary Mucinous Neoplasm - p. 481 165. Chapter 139: Intraductal Oncocytic Papillary Neoplasm - p. 487 166. Chapter 140: Intraductal Tubulopapillary Neoplasm - p. 489 167. Chapter 141: Solid Pseudopapillary Neoplasm - p. 491 168. Chapter 142: Pancreatoblastoma - p. 495 169. Chapter 143: Dermoid Cyst - p. 497 170. Chapter 144: Specimen Handling, Whipple - p. 499 171. SECTION 6: TUMORS OF THE AMPULLA - p. 503 172. Chapter 145: Ampullary Adenoma - p. 503 173. Chapter 146: Ampullary Adenocarcinoma and Histologic Subtypes - p. 507 174. Chapter 147: Well-Differentiated Neuroendocrine Tumor, Ampulla - p. 511 175. Chapter 148: Gangliocytic Paraganglioma - p. 513 176. INDEX - p. 515
